Skip to content
healthcare.dev

Topricin

NDC 61500-5547, aesculus hippocastanum, arnica montana, belladonna, calendula officinalis, crotalus horridus, echinacea, graphites, heloderma horridum, lachesis mutus, naja tripudians, phosphorus, rhus toxicodendron, ruta graveolens, sulfur, cream, from Topical BioMedics, Inc..

Product NDC
61500-5547
Status
Listed
Labeler
Topical BioMedics, Inc.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61500-5547 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHOSPHORUS9 [hp_X]/227g
  • ARNICA MONTANA6 [hp_X]/227g
  • CROTALUS HORRIDUS HORRIDUS VENOM8 [hp_X]/227g
  • ECHINACEA ANGUSTIFOLIA4 [hp_X]/227g
  • GRAPHITE6 [hp_X]/227g
  • HELODERMA HORRIDUM VENOM8 [hp_X]/227g
  • LACHESIS MUTA VENOM8 [hp_X]/227g
  • NAJA NAJA VENOM8 [hp_X]/227g
  • RUTA GRAVEOLENS FLOWERING TOP6 [hp_X]/227g
  • AESCULUS HIPPOCASTANUM FLOWER6 [hp_X]/227g
  • ATROPA BELLADONNA6 [hp_X]/227g
  • TOXICODENDRON PUBESCENS LEAF8 [hp_X]/227g
  • CALENDULA OFFICINALIS FLOWERING TOP4 [hp_X]/227g
  • SULFUR8 [hp_X]/227g
Package NDCNDC-11Package
61500-5547-0615005547002 g in 1 PACKET (61500-5547-0)
61500-5547-16150055470121 g in 1 TUBE (61500-5547-1)
61500-5547-26150055470257 g in 1 TUBE (61500-5547-2)
61500-5547-461500554704113 g in 1 JAR (61500-5547-4)
61500-5547-861500554708454 g in 1 BOTTLE (61500-5547-8)
61500-5547-961500554709227 g in 1 BOTTLE (61500-5547-9)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 61500-5547 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61500-5547 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61500-5547. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.